← Leaderboards
Gerard Joseph Marek
Yale University
$8,829,545
Attributed
$11,829,545
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,829,545 · 4
By mechanism
UG3$11,439,548 · 2
K08$253,802 · 1
R01$136,195 · 1
Top collaborators
- Jay Erdman1 shared
Most similar at Yale University
Same institution · by research overlap
- Sandra Ann Springer$27,149,168
- Gail D'onofrio$17,031,011
- Edward Robert Melnick$8,404,377
- Traci C Green$12,396,952
- Alison Oliveto Beaudoin$13,435,140
Others in their field
Top investigators on “Prefrontal Lobe /Cortex”
- Patricia S Goldman-Rakic · Yale University$9,356,246
- Harvey S Levin · Baylor College Of Medicine$8,991,957
- David A Lewis · University Of Pittsburgh At Pittsburgh$7,112,169
- Mark D'esposito · Va Northern California Health Care Sys$5,474,182
- John Gabrieli · Rush University Medical Center$4,883,652
- Robert Henry Roth · Yale University$4,745,097
Research focus
Prefrontal Lobe /CortexSecondary EndpointGrantPharmaceutical PreparationsRattusSafetyDoseGlutamatesNeural TransmissionOpioid Use DisorderPrimary EndpointProtein Structure FunctionReceptorReceptor ExpressionClinical ResearchCravingDrug KineticsFda ApprovedMonitorCardiacOpioidOpioid EpidemicClinical TrialsSedation Procedure
Grant awards (6)
Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder$2,692,397
UG3 · FY2025 · DA · contact PI
Development of a Safer and More Effective Ibogaine Analog for the Treatment of Opioid Use Disorder$2,747,151
UG3 · FY2024 · DA · contact PI
Evaluation of the Safety and Efficacy of a New Oral Small Molecule GABA-B Receptor Positive Allosteric Modulator (PAM) as an Add-on Maintenance Therapy for Opioid Use Disorder (OUD)$6,000,000
UG3 · FY2020 · DA
Serotonin Glutamate Interactions in Prefrontal Cortex$136,195
R01 · FY2001 · MH
SEROTONIN MODULATION OF NEUROTRANSMISSION IN NEOCORTEX$127,927
K08 · FY2001 · MH
SEROTONIN MODULATION OF NEUROTRANSMISSION IN NEOCORTEX$125,875
K08 · FY2000 · MH